LAUSR

Reevaluating Liver Donor Risk in the Era of Improved Hepatitis C Virus Treatment.

Sign Up to like & get
recommendations!
2 Published in 2022 at "JAMA surgery"

DOI: 10.1001/jamasurg.2022.3922

Abstract: This cohort study examines the risk of graft failure associated with donors with hepatitis C virus (HCV) infection before and after the introduction of direct-acting antiviral medications. read more here.

Keywords: reevaluating liver; hepatitis virus; risk; liver donor ... See more keywords